Kurmasheva, N., Said, A., Wong, B., Kress, A., Liu, Z., Wang, C.
, Carter-Timofte, M. E., Holm, E., van der Horst, D., Hoang, H.-D.
, Twayana, K. S., Ottosen, R., Svenningsen, E. B., Begnini, F., Kiib, A. E., Weiss, H., Di Carlo, D., Muscolini, M., Higgins, M.
... Olagnier, D. P. C. (2023).
Itaconate enhances oncolytic virotherapy by multitarget inhibition of antiviral and inflammatory pathways. (1 ed.) Research Square 2023.
https://doi.org/10.21203/rs.3.rs-3035315/v1
Kirkeby, A., Nelander, J., Hoban, D. B., Rogelius, N., Bjartmarz, H., Novo Nordisk Cell Therapy R&D, Storm, P., Fiorenzano, A., Adler, A. F., Vale, S., Mudannayake, J., Zhang, Y., Cardoso, T., Mattsson, B.
, Landau, A. M., Glud, A. N., Sørensen, J. C., Lillethorup, T. P., Lowdell, M. ... Parmar, M. (2023).
Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson's disease, STEM-PD.
Cell Stem Cell,
30(10), 1299-1314.e9.
https://doi.org/10.1016/j.stem.2023.08.014